ArabFinance: El Nile Company for Pharmaceuticals and Chemical Industries (Nile Pharma) (NIPH) posted a 40.1% year-on-year (YoY) increase in net profit after tax during the period ended June 30th, recording EGP 90.255 million, according to financial indicators filed to the Egyptian Exchange (EGX) on Tuesday.
Revenues went up by 17.2% YoY to EGP 885.584 million by the end of June.
Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.